Metacognitive therapy for fear of cancer recurrence
Part of Mental health clinical trials.
This study tests a type of therapy called metacognitive therapy to help cancer survivors who are afraid their cancer might come back. It aims to see if this therapy can reduce that fear and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You had stage I, II, or III cancer and have finished your main treatment (like surgery, chemo, or radiation).
- You understand and read Chinese (Mandarin) and do not have memory or thinking problems.
- You often worry about the cancer coming back (a score of 13 or higher on a special fear scale).
- You do not have a severe mental health condition that is not being treated.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a program to help Chinese-speaking cancer survivors manage their fear of cancer coming back. You may join if you have worries about recurrence but at a level that is not severe.
This study tests two online programs—Emotional Freedom Techniques (tapping) and mindfulness meditation—to help cancer survivors reduce fear of their cancer coming back. You may join if you finished cancer treatment within the last 5 years and have significant worry about recurrence.
This trial tests an online program to help Chinese cancer survivors who have a moderate fear of their cancer returning. It is for people who recently finished treatment for early-stage colorectal or breast cancer.
This study compares two talking therapies to help reduce the fear that cancer might come back. It is for cancer survivors and their spouses or partners, and aims to find which approach works better for both.
This trial is testing a program led by a clinician (like a doctor or nurse) to help people who are worried about their cancer returning. It's for people who recently finished treatment for breast, ovarian, prostate, or lung cancer.
This trial tests if cognitive behavioral therapy can reduce fear of cancer recurrence in women with BRCA1/2 mutations who have finished treatment for breast or ovarian cancer. It aims to help you cope with worries about cancer coming back.
Hear when a new Fear of Cancer Recurrence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.